[{"Assets_0_Q2_USD":265004000.0,"CommonStockSharesOutstanding_0_Q2_shares":14658.0,"EarningsPerShareBasic_1_Q2_USD":0.78,"EarningsPerShareBasic_2_Q2_USD":1.16,"EarningsPerShareDiluted_1_Q2_USD":0.76,"EarningsPerShareDiluted_2_Q2_USD":1.12,"NetIncomeLoss_1_Q2_USD":11369000.0,"NetIncomeLoss_2_Q2_USD":16862000.0,"StockholdersEquity_0_Q2_USD":244138000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":15044000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":15046000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":14588000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":14582000.0,"Ticker":"ANIK","CIK":"898437","name":"ANIKA THERAPEUTICS, INC.","OfficialName":"Anika Therapeutics Inc. Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"337949354.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20170728"}]